The integration of multi-gene parallel analysis using Next-Generation Sequencing (NGS) has revolutionized the capacity of German diagnostic laboratories to provide comprehensive tumor profiling from a single blood draw in 2025. This technology allows for the simultaneous screening of hundreds of genomic regions, identifying not only point mutations but also insertions, deletions, and copy...